Acute otitis media (AOM)

Definition/Description

Presence of inflammation in the middle ear, associated with an effusion and accompanied by the rapid onset of clinical features of an ear infection

Uncomplicated: mild pain of <4 days and an absence of red or amber features
Complicated: severe pain, bilateral infection, mastoiditis, labyrinthitis, facial nerve palsy

Paediatric Normal Values (adapted from APLS)

Age

Resp Rate

Heart Rate

Systolic BP

Neonate <4w

40-6

120-160

>60

Infant <1 y

30-40

110-160

70-90

Toddler 1-2 yrs

25-35

100-150

75-95

2-5 yrs

25-30

95-140

85-100

Red Flag Symptoms

Exclude Red Flag Symptoms

  • Features of mastoiditis
  • Intracranial infection can occur in absence of mastoiditis, signs include
    • Increasing drowsiness
    • Meningism/irritability
    • Severe headache persisting despite regular analgesia or worse on lying down/in the morning
    • Persistent vomiting
    • Severe retroorbital pain
    • New onset squint or diplopia – covering up one eye
    • Deteriorating vision – complaining of blurred vision
    • New limb weakness – may exhibit change of hand preference
    • Unsteady gait or coordination issues
    • Pain beyond ears, extensive headache or facial pain
  • Haemodynamic instability/shock

 

Low Threshold for Admission

  • Age <3 months
  • Age 3-6 months with temperature ³ 39°C
  • Craniofacial syndromes, e.g. Down’s syndrome, cleft palate
  • Immunodeficiency
  • Cochlear implant

Guidelines on Management

General Points

  • One of the most common diseases in infants and children
  • Peak incidence between 6 and 15 months; 75% occur in children under 10 years
  • Usually a self-limiting infection and most will experience symptom resolution within 4-7 days with symptomatic treatment only
  • Respiratory viral infections usually precede or coincide with AOM in children
  • Complications are rare in otherwise health patients from developed countries

Differential Diagnoses

Clinical Feature

Otitis Externa

Otitis Media

Ear pain

Yes

Yes, often improved when
discharge commences

Discharge

Scanty

Mod/severe mucopurulent

Hearing

Later onset muffled

Early onset

Preceding URTI

No

Often

Tender ear canal

Yes, very

No

Periauricular swelling

Yes in severe secondary to soft tissue cellulitis

No unless mastoiditis

Canal swelling

Yes

No

Ear drum

Can be difficult to visualise due to canal debris

Red bulging, oedematous,
perforated

Associated with intracranial complication

No (unless immunocompromised) 

Yes

 

Assessment

  • New/rapid (days) onset earache and associated loss or reduction in hearing
  • In younger children
    • Pulling, tugging or rubbing of the ear
    • Non-specific symptoms, e.g. fever, irritability, crying, poor feeding, restlessness at night, cough, rhinorrhoea
  • Otoscopic appearance: bulging tympanic membrane with loss of landmarks, changes in membrane colour (red or yellow), perforation, discharge of pus
  • Examine mastoid for tenderness, erythema and swelling
  • Note any cervical lymph node enlargement

Referral Criteria/Information

When to Arrange Emergency Hospital Admission

  • Severe systemic infection
  • Suspected complications of AOM such as meningitis, mastoiditis, intracranial abscess, sinus thrombosis or facial nerve paralysis

Low Risk for Community Management

  • No antibiotics: seek advice if symptoms worsen rapidly or significantly, do not improve after 3 days or becomes systemically unwell.
  • Delayed antibiotics: start if symptoms do not start to improve within 3 days. Seek medical advice if symptoms worsen rapidly or significantly
  • Immediate antibiotics: Give a 5-7 day course.

Community Antibiotic Treatment

Antimicrobial therapy should considered in the following groups

  • Otorrhoea
  • Age <2y with bacterial infection

 

Drug

Age

Weight

Dose

First Line Options

Amoxicillin

1-11m

125 mg TDS

1-4y

250 mg TDS

5-17y

500 mg TDS

Can be added if there is no response to Amoxicillin. Use first line if penicillin allergic

Clarithromycin

1m-11y

<8kg

7.5mg/kg BD

8-11kg

62.5 mg BD

12-19kg

125 mg BD

20-29kg

187.5mg BD

30-40kg

250mg BD

12-18y

250mg BD

Second Line Options (should be used in pneumonia associated with influenza)

Co-amoxiclav

1-11m

0.25ml/kg of 125/31 suspension TDS

1-5y

5ml of 125/31 suspension TDS

6-11y

5ml of 250/62 suspension TDS

12-17y

250/125mg or 500/125mg tablets TDS

Seek microbiologist advice in penicillin allergy

 

Referral Information

Indications for referral to ENT

  • If ear discharge (otorrhoea) persists for 2 weeks
  • If perforation of the tympanic membrane has occurred
  • If hearing loss persists in the absence of pain or fever
  •  Recurrent acute otitis media (³3 episodes in 6m or ³4 episodes in 12m)

Additional Resources & Reference

Patient information leaflets/ PDAs

RSS Parent leaflet

Patient.info leaflet

 

References

  • National Institute for Clinical Excellent [NICE] (2018) Otitis media (acute): anrtimicrobial prescribing NG91[Viewed 12 Nov 2021] https://www.nice.org.uk/guidance/ng91 
  • Venekamp RP, Sanders SL, Glasziou PP et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2015; https://dx.doi.org/10.1002/14651858.CD000219.pub4: CD000219.
  • Venekamp RP, Damoiseaux RA, Schilder AG. Acute otitis media in children. BMJ Clin Evid 2014; 2014.
  • Lording A, Patel S, Whitney A. Intracranial complication of ear, nose and throat infections in childhood. Journal of ENT Masterclass 2017; 10: 64-70.
  • Patel S, et al. Paediatric Pathways: Acute Otitis Media (AOM) and Mastoiditis Pathway for Children Presenting to Hospital. British Society for Antimicrobial Chemotherapy https://bsac.org.uk/paediatricpathways/otitis-media-mastoiditis.php [Viewed 12 Nov 2021]

Associated Policies

There are no associated policies.

Specialties

Places covered by

  • Vale of York

Hospital Trusts

  • York and Scarborough Teaching Hospitals
Author: Responsible GP: Dr Rebecca Brown / Responsible Consultant: Dr Rebecca Proudfoot / Responsible Pharmacist: Faisal Majothi
Date created: 30/07/2025, 09:13
Last modified: 30/07/2025, 15:08
Date of review: 30/04/2027